Research / Stocks / CLFD CLFD Nasdaq CIK 0000796505
Clearfield, Inc. · Telephone & Telegraph Apparatus
COVERAGE / STANDARD
Latest filing 10-Q · Aug 6, 2026
Research state Latest filing analysis is current
Last SEC check Sep 13, 2026
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT Clearfield, Inc.'s latest supported as-filed period reports revenue of $43.9M ; gross margin moved 126 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Capex intensity 10th Own-history percentile · N=10
Method Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.07% · OPTIONAL
Revenue growth RAW Current state valid · history insufficient
Method Yoy · gp.fundamentals.revenue
Raw value -12.10% · CORE
Inventory pressure 20th Own-history percentile · N=10
Method Level · gp.fundamentals.inventory_revenue_ratio
Raw value 76.12% · OPTIONAL
Gross margin 70th Own-history percentile · N=10
Method Level · gp.fundamentals.gross_margin
Raw value 31.79% · CORE
Operating margin 100th Own-history percentile · N=10
Method Level · gp.fundamentals.operating_margin
Raw value 5.86% · CORE
SBC intensity 0th Own-history percentile · N=10
Method Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2.34% · OPTIONAL
Inspect state history and evidence → 6 dimension transitions in this filing Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Jun 30, 2026 General Corporate
Capital Allocation 2 evidence-backed dimensions Capex Intensity Inflecting Sbc Intensity Inflecting [email protected] · 11 historical states · 38% confidenceCompany Direction 6 evidence-backed dimensions Capex Intensity Inflecting Inventory Pressure Improving Margin Deteriorating Profitability Inflecting Sbc Intensity Inflecting [email protected] · 11 historical states · 38% confidenceFinancial Quality 4 evidence-backed dimensions Inventory Pressure Improving Margin Deteriorating Profitability Inflecting Sbc Intensity Inflecting [email protected] · 11 historical states · 38% confidenceGovernance Evidence 4 evidence-backed dimensions Filing Amendments None Detected Auditor Changes Observed Sbc Intensity Observed Insider Activity Observed [email protected] · 11 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
INSIDER STATE / 90D Recent disclosed activity
Open-market purchases 0
Sales 0
Distinct buyers 0
Repeat buyer NO Conservative Form 4 classification · not a sentiment label Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0001171843-26-005329 10 governed changes · top 7 shown
01
HIGH IMPORTANCE Cash 33TH HISTORICAL PCTL · N=3
Cash & equivalents decreased 39.6% Cash & equivalents changed -39.6% from the comparable as-filed period.
Why this ranks here · [email protected] $33.9M → $20.4M Comparable → current
02
LOW IMPORTANCE Margin 0TH HISTORICAL PCTL · N=2
Gross margin moved 126 bp higher Gross margin changed +126 basis points from the comparable as-filed period.
Why this ranks here · [email protected] 30.53% → 31.79% Comparable → current
03
LOW IMPORTANCE Margin 0TH HISTORICAL PCTL · N=2
Gross profit decreased 8.5% Gross profit changed -8.5% from the comparable as-filed period.
Why this ranks here · [email protected] $15.2M → $13.9M Comparable → current
04
HIGH IMPORTANCE Inventory 67TH HISTORICAL PCTL · N=3
Inventory decreased 37.9% Inventory changed -37.9% from the comparable as-filed period.
As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 2.07% -30.0% ↓ Capital expenditure $910,000 -10.7% ↓ Cash & equivalents $20.4M +0.0% ↑ Debt $2.4M +8.9% ↑ Free-cash-flow proxy $7.5M +1048.5% ↑ Gross margin 31.79% +0.0% ↑ Interest expense $106,000 +53.6% ↑ Inventory $33.4M -9.6% ↓
ACTIVE TRACE Revenue CLFD · as filed with the SEC · reported-date aware
Capex / revenue Q3 / 2026-06-30 2.07% -30.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q3 / 2026-06-30 $910,000 -10.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q3 / 2026-06-30 $20.4M +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Debt Q3 / 2025-06-30 $2.4M +8.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q3 / 2025-06-30 $7.5M +1048.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Gross margin Q3 / 2026-06-30 31.79% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Interest expense Q3 / 2025-06-30 $106,000 +53.6% sequential point Trace ↗ Evidence inspector
Loading lineage… × Inventory Q3 / 2026-06-30 $33.4M -9.6% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q3 / 2026-06-30 $3.0M +668.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q3 / 2025-06-30 $7.9M +159.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q3 / 2026-06-30 5.86% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Research & development FY / 2025-09-30 $2.4M -19.3% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
10-Q Aug 6, 2026 Period Jun 30, 2026 0001171843-26-005329SEC ↗ 8-K Aug 5, 2026 Period Aug 5, 2026 0001171843-26-005241SEC ↗ 8-K Jul 28, 2026 Period Jul 24, 2026 0001171843-26-004903SEC ↗ 4 Jul 6, 2026 Period Jul 1, 2026 0000796505-26-000023SEC ↗ 4 Jul 2, 2026 Period Jun 30, 2026 0000796505-26-000022SEC ↗ 4 Jul 2, 2026 Period Jun 30, 2026 0000796505-26-000021SEC ↗ 4 Jul 2, 2026 Period Jun 30, 2026 0000796505-26-000020SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗